Showing results (261-270 of 623) with videos related to

Sort By:
Pageof 63
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 223Ra: PARABO, a Prospective, Noninterventional StudyHolger Palmedo, Hojjat Ahmadzadehfar, Susanne Eschmann, et al.
Liver Cancer|January 23, 2026
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with BevacizumabMatthias Jeschke, Julia M Schütte, Stephan Himmen, et al.
Radiology|December 9, 2025
Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PETSungmin Woo, Benedetta Masci, Steven P Rowe, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 8, 2019
Post-radiosynovectomy imaging utilizing Erbium-169 citrateJamshid Farahati, Sandra Kazek, Ines Maric, et al.
Endocrine|September 4, 2021
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyHarald Lahner, Annie Mathew, Anna Lisa Klocker, et al.
EJNMMI Physics|January 3, 2024
Biodistribution and radiation dosimetry of 124I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsAlexandros Moraitis, Walter Jentzen, Gloria Reiter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2024
Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysisLudmila Santiago Almeida, Irene García Megías, Elba Cristina Sá Camargo Etchebehere, et al.
Theranostics|June 28, 2019
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumorsSusanne Lütje, Sandra Heskamp, Gerben M Franssen, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.
Pageof 63